Hematopoietic Stem Cell Transplantation (HSCT) Market to Witness Upward Trend Due to High Prevalence of Certain Blood Cancers
Hematopoietic Stem Cell Transplantation (HSCT) is a specialized form of blood stem cell transplant therapy. The term hematopoietic refers to the function of the stem cells in human beings. 'Stem cell' refers to specialized stem cell types which are capable of developing into specific cells like bone, muscle, blood, and nerve cells. Hematopoietic stem cell transplantation can be used in the treatment of certain cancers of the blood or bone marrow, such as multiple myeloma or leukemia. High prevalence of such diseases is expected to aid in growth of the hematopoietic stem cell transplantation (HSCT) market. According to Leukemia and Lymphoma Society, 176,200 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma in 2019. The hematopoietic stem cell transplantation (HSCT) market in North America is witnessing high growth, owing to high adoption of allogeneic hematopoietic stem cell transplant. Around 30,000 patients undergo allogeneic hematopoietic...